* 7 transdermal therapeutic systems (TTS). (Organic nitrate for use in coronary heart disease).
* 1,2,3-propanetriol trinitrate (=Nitroglycerin) 25 mg in a transdermal therapeutic system (TTS) act.prolongat. in vivo release = 5 mg / 24h.
* Store below 25 degrees C. Systems should be kept out of the reach of children both before and after use.
* Packed by: NOVARTIS PHARMA S.A.E.,
under licence from: Novartis Pharma AG., Basle, Switzerland.